---
category: news
title: "Bridge Bio will use Brainomix AI in lung fibrosis trial"
excerpt: "Brainomix has reeled in another pharma partner for its artificial intelligence-powered biomarker software ... ILD software package in a phase 2 trial of BBT-877, its experimental therapy for serious lung disease idiopathic pulmonary fibrosis (IPF)."
publishedDateTime: 2022-09-07T11:03:00Z
originalUrl: "https://pharmaphorum.com/news/bridge-bio-will-use-brainomix-ai-in-lung-fibrosis-trial/"
webUrl: "https://pharmaphorum.com/news/bridge-bio-will-use-brainomix-ai-in-lung-fibrosis-trial/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: pharmaphorum
  domain: pharmaphorum.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://pharmaphorum.com/wp-content/uploads/2020/01/iStock-926015820.jpg"
    width: 1200
    height: 676
    isCached: true

secured: "iKtrsKn8VRYTm5bZ2cjtczsmFElkBWpW5FbT0yowG7pGCBeoj1AbBAjYFlz6Yrw8V14nKc4CaCVaHRyouqiZh5ZmenvOwt+vTjEmmPX6UX0dlbt+t8oEe70WyP+8BsjyPr/gtG/qM6GJNXo0DeRCOcsqfF0twGKwCYwYamlD4VOHZ55yhmZYhkUO5In7UQSDIoUcJJigrqOJLzSVVIA4JJltlMUKJ0IegFnAZIsDt4wznlZv46mT6ie3GFtDGM8bZ2QK8HLqZCu+nhBjo6dLl6BTPwVG6jwAQ1imjS57A6nVGtR7W2h9tfoP+q0OsaXjWhPGaMJTxBjSnMHxYzonOfJwJ3b5bQY3ZPR4eMAFZJg=;kvxUY1YYPHIaj3xR7oJziw=="
---

